003022 联泓新科
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.9264.1653.2646.34713.053
总资产报酬率 ROA (%)0.5701.3871.2832.8716.626
投入资产回报率 ROIC (%)0.6381.5521.4153.2237.443

边际利润分析
销售毛利率 (%)23.30318.71716.50116.16020.222
营业利润率 (%)9.1795.4645.0727.66010.547
息税前利润/营业总收入 (%)11.7607.3456.2218.96811.933
净利润/营业总收入 (%)8.1875.0094.2406.73210.713

收益指标分析
经营活动净收益/利润总额(%)100.71385.68425.51938.26679.787
价值变动净收益/利润总额(%)0.5661.32813.843-0.4410.301
营业外收支净额/利润总额(%)-0.340-0.191-5.4460.331-0.288

偿债能力分析
流动比率 (X)0.6770.5310.6070.7001.055
速动比率 (X)0.5270.4060.5040.5860.866
资产负债率 (%)68.22966.97259.73954.00947.537
带息债务/全部投入资本 (%)65.83262.69656.71349.76339.753
股东权益/带息债务 (%)48.36755.11071.45993.757140.486
股东权益/负债合计 (%)42.50645.19962.09877.453103.825
利息保障倍数 (X)4.5023.8834.4096.9928.426

营运能力分析
应收账款周转天数 (天)11.49210.9359.2869.8257.848
存货周转天数 (天)57.58056.91344.95941.60034.929